1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Small Animal Imaging (In-Vivo) Market

4.1. Industry Value Chain Analysis
4.1.1. Sample Collection
4.1.2. Sample Preparation & Validation
4.1.3. Service Provider
4.1.4. End Use

4.2. Industry Outlook

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019 - 2032
4.7.2. Price Trend Analysis, By Type Test

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping 

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
5.2.1. CT Imaging
5.2.2. MRI Imaging
5.2.3. Nuclear Imaging System
5.2.4. Optical Imaging System
5.2.5. Ultrasound Imaging
5.2.6. Photoacoustic Imaging
5.2.7. Magnetic Particle Imaging (MPI)

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
6.2.1. Monitoring treatment response
6.2.2. Bio-distribution, determining drug/target engagement
6.2.3. Cancer cell detection
6.2.4. Biomarkers
6.2.5. Epigenetics
6.2.6. Others

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
7.2.1. Biotech Companies
7.2.2. Pharmaceutical companies
7.2.3. Research institutes

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
8.2.1. North America
8.2.1.1. The U.S.
8.2.1.2. Canada
8.2.1.3. Mexico
8.2.2. Europe
8.2.2.1. UK
8.2.2.2. Germany
8.2.2.3. France
8.2.2.4. Italy 
8.2.2.5. Spain
8.2.2.6. Russia
8.2.2.7. Poland
8.2.2.8. Rest of Europe
8.2.3. Asia Pacific
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia + New Zealand
8.2.3.5. South Korea
8.2.3.6. ASEAN
8.2.3.7. Rest of Asia Pacific
8.2.4. Middle East & Africa (MEA)
8.2.4.1. UAE
8.2.4.2. Saudi Arabia
8.2.4.3. South Africa
8.2.4.4. Rest of MEA
8.2.5. South America
8.2.5.1. Brazil
8.2.5.2. Argentina
8.2.5.3. Rest of South America

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
9.2.1. By Modality 
9.2.2. By Application
9.2.3. By End Use
9.2.4. By Country 

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
10.2.1. By Modality 
10.2.2. By Application
10.2.3. By End Use
10.2.4. By Country 

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
11.2.1. By Modality
11.2.2. By Molecule Type
11.2.3. By Application
11.2.4. By End Use

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
12.2.1. By Modality
12.2.2. By Application
12.2.3. By End Use
12.2.4. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
13.2.1. By Modality
13.2.2. By Application
13.2.3. By End Use
13.2.4. By Country

14.1. Bruker Corporation
14.2. Siemens A.G.
14.3. Agilent Technologies
14.4. Fujifilm Corporation
14.5. Hologic, Inc.
14.6. Mediso Ltd.
14.7. TriFoil Imaging
14.8. PerkinElmer
14.9. MILabs B.V.
14.10. MR Solutions
14.11. Thermo Fisher Scientific
14.12. Others major players